Table 5.
The effectiveness of probiotics for treatment of mixed FAPD
| First author (year) | Number of participants | Probiotics | Outcome and measurement unit | Results in intervention(I)/ control group (C) | Statistical test results (P-value) |
|---|---|---|---|---|---|
| Jadresin (2017) | 55 | Lactobacillus reuteri 17938 | Number of days without pain (n) | I: 89.5 (Range=5–108) C: 51 (Range=0–107) |
0.029* |
| Change in pain severity by WBFS | I: 0.42 (Range=−0.31–2.9) C:0.23 (Range=−1.2–2.2) |
0.481 | |||
| Changes in pain duration (minutes) | I: 6.3 (Range=−40–170) C: 23 (Range=−32–395) |
0.143 | |||
| Complete resolution of pain (n) | I: 61.5% (n=16) C: 55.2% (n=16) |
0.633 | |||
| Changes in pain duration (minutes) | I: 19.310 C: 1.800 |
0.012* |
WBFS Wong-Baker faces scale.
*Statistically significant.